Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Is a Short Squeeze Coming in Cassava Sciences (SAVA) Stock?

Today, a rally across most meme stocks has investors looking at Cassava Sciences and SAVA stock due to the short interest in this stock.

Why Is STEM Stock Up 10% Today?

A key analyst upgrade today is leading to outsized interest in renewable energy storage company Stem and STEM stock.

Jerome Powell Dances Around Rate Hike News. Stocks Are Up Today.

As Federal Reserve chairman Jerome Powell delivered his speech today, investors paid close attention, and started hitting the bid.

3 Electric Vehicle Stocks to Buy to Electrify Your Portfolio in 2023

Here's why these three electric vehicle stocks should at least be on investors' radar as we start the new year off with a bang.

3 Cryptocurrencies Worth Buying Before the Crypto Winter Thaws

Those concerned about crypto winter have reason to be, but these three top cryptos are certainly worth a look for the long term.

PRTY Stock Alert: Near-Bankrupt Party City Braces for Short Squeeze

Will investors in embattled party retailer Party City and PRTY stock be able to crack open the champagne, or left by the roadside?

Why Is QuantumScape (QS) Stock Up 10% Today?

Today, investors in solid-state batter technology company QuantumScape and QS stock are hitting the bid, as shares rocket higher.

3 Tech Companies to Watch in 2023

These three tech companies were each among the most-watched stocks of 2022, and that shouldn't change in 2023.

Lecanemab Alert: What Would Alzheimer’s Drug Approval Mean for Biogen (BIIB) Stock?

Biogen is in focus today with the company's lecanemab drug set for an FDA decision on approval, leading to bullish bets on BIIB stock.

Is Ryan Cohen Going to Save Bed Bath & Beyond (BBBY) Stock?

Some investors in embattled retailer Bed Bath & Beyond and BBBY stock are pricing in the potential for Ryan Cohen to join the fray once again.